SPX3,693.23-64.76 -1.72%
DIA295.86-4.66 -1.55%
IXIC10,867.93-198.88 -1.80%

Aldeyra Therapeutics On Track to File New Drug Application for Dry Eye Disease Drug Candidate in Q4

Aldeyra Therapeutics On Track to File New Drug Application for Dry Eye Disease Drug Candidate in Q4

MT Newswires · 09/14/2022 06:06

Please log in to view news